CASTELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 29.298
EU - Europa 14.644
AS - Asia 6.426
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 38
OC - Oceania 30
SA - Sud America 26
Totale 50.566
Nazione #
US - Stati Uniti d'America 29.173
UA - Ucraina 5.025
CN - Cina 4.519
IT - Italia 2.767
DE - Germania 1.942
PL - Polonia 1.331
HK - Hong Kong 1.279
FI - Finlandia 1.065
IE - Irlanda 851
GB - Regno Unito 763
FR - Francia 355
SE - Svezia 341
IN - India 281
CA - Canada 120
TR - Turchia 117
SG - Singapore 84
BE - Belgio 74
VN - Vietnam 62
MU - Mauritius 52
RU - Federazione Russa 50
EU - Europa 38
AU - Australia 27
IR - Iran 27
NL - Olanda 19
BR - Brasile 16
JP - Giappone 12
RO - Romania 12
ES - Italia 9
CI - Costa d'Avorio 8
BF - Burkina Faso 7
KR - Corea 7
AT - Austria 6
CH - Svizzera 6
SA - Arabia Saudita 6
ZA - Sudafrica 6
ID - Indonesia 5
GF - Guiana Francese 4
HR - Croazia 4
MK - Macedonia 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
TZ - Tanzania 4
UG - Uganda 4
ZM - Zambia 4
KE - Kenya 3
MA - Marocco 3
MD - Moldavia 3
MM - Myanmar 3
MX - Messico 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TH - Thailandia 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BG - Bulgaria 2
CD - Congo 2
EC - Ecuador 2
ET - Etiopia 2
IL - Israele 2
IQ - Iraq 2
JO - Giordania 2
KZ - Kazakistan 2
NG - Nigeria 2
AL - Albania 1
AO - Angola 1
BJ - Benin 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 50.566
Città #
Jacksonville 3.633
Fairfield 3.589
Woodbridge 2.880
Chandler 2.141
Wilmington 1.993
Ashburn 1.847
Houston 1.720
Princeton 1.603
Cambridge 1.467
Ann Arbor 1.464
Seattle 1.411
Warsaw 1.327
Hong Kong 1.274
Nanjing 1.226
Dublin 842
New York 683
Beijing 520
Helsinki 470
Nanchang 423
Des Moines 357
Shenyang 309
Brescia 295
Hebei 264
Changsha 262
San Diego 233
Tianjin 218
Dearborn 202
Milan 201
Jinan 198
Jiaxing 195
Kunming 140
Hangzhou 126
Verona 114
Shanghai 109
Kocaeli 94
Boardman 88
Mcallen 83
Munich 80
Ningbo 77
London 73
Brussels 72
Zhengzhou 69
Lanzhou 67
Dong Ket 58
Toronto 57
Norwalk 56
San Francisco 55
Lancaster 48
Rome 46
Taizhou 45
Haikou 41
Montréal 39
Washington 39
Los Angeles 36
Pune 36
Guangzhou 34
Leawood 34
Augusta 30
Taiyuan 30
Changchun 29
Kilburn 29
Auburn Hills 26
Falls Church 25
San Mateo 25
Fuzhou 24
Hefei 20
Monmouth Junction 20
Orange 20
Ardabil 16
Bergamo 16
Redmond 15
Redwood City 15
Napoli 14
Bologna 13
Cazzago San Martino 12
Hanover 12
Indiana 12
Melbourne 12
Torino 12
Acton 11
Chiswick 11
Ottawa 11
Westminster 11
Hounslow 10
Lappeenranta 10
Moscow 10
Tokyo 10
Chicago 9
Florence 9
Mountain View 9
Palermo 9
Abidjan 8
Canberra 8
Islington 8
Nürnberg 8
Sydney 8
São Paulo 8
Turin 8
Brignano Gera d'Adda 7
Catania 7
Totale 35.680
Nome #
Influence of maternal CD4+ levels on the predictive value of virus load mother-to-child transmission of HIV type 1 (HIV-1) 371
The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia 229
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 225
Cos’è la Medicina Tropicale 220
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 209
Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016 201
Arboviral and other illnesses in travellers returning from Brazil, june 2013 to may 2016: Implications for the 2016 olympic and paralympic games 189
Hcverso1 and 2: Faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection 179
Proceedings of the IV Congress of the University Network for Development Cooperation (CUCS) “Rinforzare il capitale umano nei paesi a risorse limitate: health and wealth for all by the year 2030” 176
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 171
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: Results from the Italian MASTER Cohort 167
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 161
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 161
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 159
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 156
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 154
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 153
Malaria chemoprophylactic recommendations for immigrants to Europe, visiting relatives and friends - a Delphi method study 140
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 138
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 135
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 132
Towards tuberculosis elimination: An action framework for low-incidence countries 130
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 130
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 129
A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from singapore 126
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV 126
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 126
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 122
Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study 122
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 121
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 120
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 120
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 119
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study 118
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 118
Variability in malaria prophylaxis prescribing across Europe: a Delphi method analysis 117
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 116
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 115
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 114
Advances in the treatment of malaria 113
Migration Medicine: the Challenge of Tuberculosis 112
Breast cancer among human immunodeficiency virus (HIV)-infected patients: the experience in Brescia, Northern Italy. 112
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 112
STI epidemics in the Indian Ocean Region: can the phase be assessed? 111
Accidental and transfusion malaria in Italy 111
CD11b expression identifies CD8(+)CD28(+) T lymphocytes with phenotype and function of both naive/memory and effector cells 111
Aetiology of acute gastro-enteritis in children at Saint Camille Medical Centre, Ouagadougou, Burkina Faso 111
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 111
ABDOMINAL AORTITIS AND ANEURYSM IMPENDING RUPTURE DURING PNEUMOCOCCAL MENINGITIS 110
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 110
Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea 109
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 109
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009 108
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 108
Algorithm based management of pneumonia in HIV-1 infected patients 107
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 107
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 107
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 107
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users 106
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 106
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 106
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 104
Vaccine preventable diseases in returned international travelers: results from the Geosentinel Surveillance Network 104
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 104
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 104
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 104
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 103
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 103
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 103
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 103
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy,1999-2009 103
Reduction of mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 102
Prevalence of anti-poliovirus type 1, 2 and 3 antibodies in unvaccinated Italian travelers 102
Vaccine Preventable Diseases in returned international Travelers: results from the Geosentinel Surveillance Network 102
Epidemiology of malaria in endemic areas 102
Non-typhoidal Salmonella aortitis 102
Prevalence and determinants of Herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy 101
Antenatal Screening for Mother to Child Infections in Immigrants and Residents: The Case of Toxoplasmosis in Northern Italy 101
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population 101
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 101
Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network 100
Epidemiological features and case-management practices of imported malaria in northern Italy 100
Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe. 100
New italian guidelines for malaria prophylaxis in travellers to endemic areas 100
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject with Solid Cancer in an Italian Multicenter Study 100
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection 99
Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008 99
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 99
Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. 99
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 99
Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in Hiv-infected patients 98
Preterm delivery risk in migrants in Italy. An observational prospective study 98
Filariasis in travelers presenting to the Geosentinel Surveillance Network 98
A Case of Rickettsia felis Infection Imported from Nepal 98
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 98
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C 98
Louse-borne relapsing fever in a refugee from Mali 98
Malaria prophylaxis. A comprehensive review 97
Leishmaniasis acquired by travellers to endemic regions in Europe – a EuroTravNet multi-centre study 97
Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from Non-EU countries in northern Italy 97
Totale 12.340
Categoria #
all - tutte 248.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 248.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.024 0 0 0 0 0 0 0 0 0 453 780 791
2019/202012.432 2.237 322 338 1.403 567 1.395 985 1.381 707 1.842 342 913
2020/20219.967 133 1.252 433 1.169 352 1.217 300 1.170 1.528 1.012 1.101 300
2021/20225.848 309 1.166 114 395 89 328 250 459 331 694 506 1.207
2022/20236.003 919 106 104 597 541 1.598 18 623 927 50 232 288
2023/20244.198 378 176 397 331 222 926 176 205 1.329 58 0 0
Totale 51.568